Form 4 Filing for Liquida Corp by Rajeev Saggar

This filing details stock transactions by Rajeev Saggar, Chief Medical Officer of Liquida Corp. On April 10, 2026, Saggar acquired 3,531 shares of Common Stock and 4,486 shares of Common Stock, both acquired as part of Performance Stock Units (PSUs) that converted to common stock. These acquisitions were made under a Rule 10b5-1 plan. Subsequently, on April 13, 2026, Saggar sold 9,220 shares of Common Stock at $38.37 per share to cover taxes related to the settlement of RSUs and PSUs. The transactions indicate a net decrease in directly held shares following the sale. Footnotes provide details on PSU conversion rates, vesting schedules, and the nature of the shares acquired and sold. The sale of shares was to cover tax obligations, as noted in footnote F6.